Protalix BioTherapeutics, Inc. (PLX) Insider Trading

Name: Protalix BioTherapeutics, Inc. (PLX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 9, 2026): Schwartz Aharon (Director): Grant/Award of 17,000 shares.

Get alerted when insiders trade PLX

Email address

Loading company data...

Loading company details...